August 2020 Clinical Watch Newsletter

September 2, 2020

In this issue of Clinical Watch, we highlight Dravet syndrome and suggest prior authorization criteria for a new anticonvulsant medication. Lastly, we review claims data for off-label use of anticonvulsants by age in children.
For more information about a topic, please contact Janelle Sheen, Karen Powell or Mary-Beth Plum. Be sure to watch for future monthly updates. For more information about our solutions, please visit conduent.com/pharmacysolutions.

Previous Flipbook
September 2020 Clinical Watch Newsletter
September 2020 Clinical Watch Newsletter

Next Article
Reassessing your CHNA and Implementation Strategies for COVID-19
Reassessing your CHNA and Implementation Strategies for COVID-19